Axsome Therapeutics, Inc. (AXSM)
234.55
+0.35
(+0.15%)
USD |
NASDAQ |
May 27, 16:00
234.55
0.00 (0.00%)
After-Hours: 16:33
Axsome Therapeutics Free Cash Flow : -70.99M for March 31, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Eli Lilly & Co. | 10.37B |
| Merck & Co., Inc. | 14.12B |
| Esperion Therapeutics, Inc. | -10.88M |
| Ocular Therapeutix, Inc. | -240.94M |
| Bristol Myers Squibb Co. | 11.91B |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -20.70M |
| Cash from Investing (Quarterly) | -0.121M |
| Cash from Financing (Quarterly) | 2.994M |
| Free Cash Flow Per Share (Quarterly) | -0.4067 |
| Free Cash Flow to Equity (Quarterly) | -22.61M |
| Free Cash Flow to Firm (Quarterly) | -17.73M |
| Free Cash Flow Yield | -0.60% |